- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07244211
Protocolo MAPT: Tratamentos Cirúrgicos de Fixação Versus Artroplastia para Recuperação Precoce Após Fratura da ANCA (FASTER-HIP) (FASTER-HIP)
Ensaio de Plataforma Adaptativa Musculoesquelética (MAPT): Tratamentos Cirúrgicos de Fixação Versus Artroplastia para Recuperação Precoce Após Fratura da ANCA (FASTER-HIP)
This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old. We hypothesize that arthroplasty will reduce death, preserve ambulation, increase days alive and out of hospital, and improve health status compared to internal fixation within 4 months and 12 months from randomization.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The Musculoskeletal Adaptive Platform Trial (MAPT) is an adaptive platform trial protocol that enables the simultaneous evaluation of multiple interventions (i.e., intervention domains) within a consistent infrastructure. Each intervention being evaluated in the MAPT will have an intervention domain protocol that describes additional eligibility criteria, interventions, secondary outcomes, and statistical stopping rules. The overarching objective of the MAPT trial platform is to incrementally decrease decisional uncertainty and identify treatments that will optimize patient outcomes. The platform focuses on the comparative effectiveness of available treatment options.
Adult patients aged 60 years or older with a low-energy minimally displaced femoral neck fracture treated with surgery are eligible for the FASTER-HIP intervention domain. Nearly half of all elderly hip fractures are femoral neck fractures, and approximately 20% are minimally displaced. Internal fixation has remained the treatment of choice for these injuries because these fractures can be fixed in situ, and the surgical implants can be inserted with little surgical dissection. Patients treated with internal fixation experience high complication rates, with the pooled risk of reoperation and mortality each above 14%. Preliminary data have suggested arthroplasty for minimally displaced fractures may lead to better patient outcomes, including improved ambulation, fewer reoperations, and a lower risk of death compared to internal fixation. While the preliminary data supporting the use of arthroplasty for minimally displaced fractures is promising, the necessary evidence to make this practice change remains lacking.
FASTER-HIP is a pragmatic, randomized, open-label, comparative effectiveness trial comparing hip arthroplasty versus internal fixation for minimally displaced femoral neck fractures. Randomization in this domain occurs in a 1:1 ratio (hip arthroplasty:internal fixation). The primary outcome is a composite of death within 120 days, ambulation status at 120 days, and days alive and out of hospital within 120 days of randomization. The primary outcome will be hierarchically assessed using the Win ratio. Secondary outcomes include the same composite at 365 days, individual components of the composite, health-related quality of life (EQ-5D-5L), and pain scores during hospitalization.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Joseph Patterson, MD
- Número de telefone: +13234426984
- E-mail: OrthoTraumaResearch@med.usc.edu
Locais de estudo
-
-
-
Ottawa, Canadá, K1H 8L6
- Ainda não está recrutando
- The Ottawa Hospital
-
Contato:
- Bradley Meulenkamp, MD
- E-mail: bmeulenkamp@toh.ca
-
Investigador principal:
- Bradley Meulenkamp, MD
-
-
British Columbia
-
Vancouver, British Columbia, Canadá, V6T 1Z4
- Recrutamento
- University of British Columbia
-
Contato:
- Aresh Sepehri, MD
-
Contato:
- E-mail: aresh.sepehri@vch.ca
-
Investigador principal:
- Aresh Sephri, MD
-
Vancouver, British Columbia, Canadá
- Recrutamento
- Fraser Health Authority
-
Contato:
- Darius Viskontas, MD
- Número de telefone: 604-777-5577
- E-mail: dariusviskontas@yahoo.ca
-
Contato:
- Número de telefone: 604-777-5577
-
Investigador principal:
- Darius Viskontas, MD
-
-
Ontario
-
London, Ontario, Canadá, N6A 5W9,
- Recrutamento
- London Health Sciences Centre
-
Contato:
- Emil Schemitsch, MD
- E-mail: emil.schemitsch@lhsc.on.ca
-
Investigador principal:
- Emil Schemitsch, MD
-
-
-
-
-
Barcelona, Espanha
- Ainda não está recrutando
- Hospital Universitari Vall d'Hebron
-
Contato:
- Carlos Alberto Piedra-Calle, MD
- E-mail: carlosalberto.piedra@vallhebron.cat
-
Investigador principal:
- Carlos Alberto Piedra-Calle, MD
-
Barcelona, Espanha
- Ainda não está recrutando
- Consorci Sanitari de l'Alt Penedès i Garraf (CSAPG)
-
Investigador principal:
- Alfred Dealbert, MD
-
Contato:
- Alfred Dealbert Dealbert, MD
- E-mail: adealbert@csapg.cat
-
Barcelona, Espanha, 08221
- Ainda não está recrutando
- Hospital Universitario Mutua de Terrassa
-
Contato:
- Pablo Castillon Bernal, MD
- E-mail: pablocastillon@mutuaterrassa.es
-
Investigador principal:
- Pablo Castillon Bernal, MD
-
Barcelona, Espanha
- Ainda não está recrutando
- FRCB-IDIBAPS (Hospital Clinic Barcelona)
-
Contato:
- Pilar Camacho, MD
- E-mail: PCAMACHO@clinic.cat
-
Investigador principal:
- Pilar Camacho, MD
-
-
-
-
California
-
Irvine, California, Estados Unidos, 92660
- Recrutamento
- University of California, Irvine
-
Investigador principal:
- Gerard Slobogean, MD
-
Contato:
- Gerard Slobogean, MD
- Número de telefone: 714-456-1699
- E-mail: gsloboge@hs.uci.edu
-
Los Angeles, California, Estados Unidos, 90048
- Recrutamento
- Cedars-Sinai Medical Center
-
Investigador principal:
- Carol Lin, MD
-
Contato:
- Carol Lin, MD
- E-mail: carol.lin@cshs.org
-
Los Angeles, California, Estados Unidos, 90033
- Recrutamento
- University of Southern California
-
Investigador principal:
- Joshua L Gary, MD
-
Contato:
- Joshua Gary, MD
- Número de telefone: +13234426984
- E-mail: OrthoTraumaResearch@med.usc.edu
-
Los Angeles, California, Estados Unidos, 90033
- Recrutamento
- Los Angeles General Medical Center
-
Investigador principal:
- Joshua L Gary, MD
-
Contato:
- Joshua Gary, MD
- Número de telefone: +13234426984
- E-mail: OrthoTraumaResearch@med.usc.edu
-
San Francisco, California, Estados Unidos, 94143
- Recrutamento
- University of California San Francisco
-
Investigador principal:
- Saam Morshed, MD
-
Contato:
- Saam Morshed, MD
- E-mail: Saam.morshed@ucsf.edu
-
-
Florida
-
Miami, Florida, Estados Unidos, 33146
- Ainda não está recrutando
- University of Miami
-
Contato:
- Giselle Hernandez, MD
- E-mail: g.hernandez@med.miami.edu
-
Investigador principal:
- Giselle Hernandez, MD
-
-
Indiana
-
Bloomington, Indiana, Estados Unidos, 47405
- Recrutamento
- Indiana University
-
Investigador principal:
- Dillon O'Neill, MD
-
Contato:
- Dillon O'Neill, MD
- E-mail: doneill5@iuhealth.org
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- Recrutamento
- University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center
-
Investigador principal:
- Mark Gage, MD
-
Contato:
- Mark Gage, MD
- E-mail: mgage@som.umaryland.edu
-
Largo, Maryland, Estados Unidos, 20774
- Recrutamento
- University of Maryland Capital Region Health
-
Investigador principal:
- Todd Jaeblon, MD
-
Contato:
- Todd Jaeblon, MD
- E-mail: tjaeblon@som.umaryland.edu
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Ainda não está recrutando
- Beth Israel Deaconess Medical Center
-
Contato:
- Ishaq Ibrahim, MD
- E-mail: ioibrahi@bidmc.harvard.edu
-
Investigador principal:
- Ishaq Ibrahim, MD
-
Boston, Massachusetts, Estados Unidos, 02115
- Recrutamento
- Massachusetts General Brigham
-
Contato:
- Michael Weaver, MD
- E-mail: MJWEAVER@BWH.HARVARD.EDU
-
Investigador principal:
- Michael Weaver, MD
-
-
Mississippi
-
University, Mississippi, Estados Unidos, 38677
- Recrutamento
- University of Mississippi
-
Investigador principal:
- Patrick Bergin, MD
-
Contato:
- Patrick Bergin, MD
- E-mail: pbergin@umc.edu
-
-
New York
-
New York, New York, Estados Unidos, 10016
- Recrutamento
- NYU Langone Health
-
Investigador principal:
- Ran Schwarzkopf, MD
-
Contato:
- Daniel Waren
- E-mail: Daniel.waren@nyulangone.org
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45221
- Recrutamento
- University of Cincinnati
-
Contato:
- Michael Beltran, MD
- E-mail: beltrame@ucmail.uc.edu
-
Investigador principal:
- Michael Beltran, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- Recrutamento
- University of Oklahoma Health Sciences Center
-
Investigador principal:
- Brandon Hull, MD
-
Contato:
- Brandon Hull, MD
- E-mail: Brandon-Hull@ou.edu
-
-
Pennsylvania
-
Allentown, Pennsylvania, Estados Unidos, 18102
- Recrutamento
- St. Luke's University Health System
-
Investigador principal:
- Dustin Greenhill, MD
-
Contato:
- Dustin Greenhill, MD
- E-mail: dustin.greenhill@sluhn.org
-
-
South Carolina
-
Greenville, South Carolina, Estados Unidos, 29601
- Recrutamento
- Prisma Health-Upstate
-
Investigador principal:
- Kyle Jeray, MD
-
Contato:
- Kyle Jeray, MD
- E-mail: kyle.jeray@prismahealth.org
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37235
- Recrutamento
- Vanderbilt University
-
Contato:
- Lauren Tatman, MD
- E-mail: lauren.m.tatman@vumc.org
-
Investigador principal:
- Lauren Tatman, MD
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84108
- Recrutamento
- University of Utah
-
Investigador principal:
- Lucas Marchand, MD
-
Contato:
- Lucas Marchand, MD
- E-mail: lucas.marchand@hsc.utah.edu
-
-
Vermont
-
Burlington, Vermont, Estados Unidos, 05405
- Ainda não está recrutando
- University of Vermont
-
Contato:
- Michael Blankstein, MD
- E-mail: michael.blankstein@uvmhealth.org
-
Investigador principal:
- Michael Blankstein, MD
-
-
Virginia
-
Fairfax, Virginia, Estados Unidos, 22031
- Recrutamento
- Inova Health Care Services
-
Investigador principal:
- Greg Gaski, MD
-
Contato:
- Grag Gaski, MD
- E-mail: greg.gaski@inova.org
-
-
Wisconsin
-
Madison, Wisconsin, Estados Unidos, 53706
- Recrutamento
- University of Wisconsin - Madison
-
Investigador principal:
- Chris Domes, MD
-
Contato:
- Chris Domes, MD
- E-mail: domes@ortho.wisc.edu
-
-
-
-
-
Grålum, Noruega, 1714
- Recrutamento
- Sykehuset Østfold HF / Østfold Hospital Trust
-
Contato:
- Frede Frihagen, MD
-
Contato:
- E-mail: Frede.Frihagen@so-hf.no
-
Investigador principal:
- Frede Frihagen, MD
-
-
-
-
-
Edinburgh, Reino Unido, EH8 8BG
- Ainda não está recrutando
- University of Edinburgh
-
Contato:
- Andrew Duckworth, MD
- E-mail: andrew.duckworth@ed.ac.uk
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- 60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture
- The patient has a health condition affecting physical mobility.
- Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging.
- Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction.
- Low energy injury mechanism.
- Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery.
Exclusion Criteria:
- The patient is not clinically suitable for either compared treatment.
- Expected injury survival of less than 12 months.
- Terminal illness with expected survival of less than 12 months.
- Incarceration.
- Unable to obtain informed consent due to language barriers.
- Unable to obtain informed consent because the legally authorized representative was unavailable.
- Problems, in the judgment of the study personnel, with maintaining follow-up with the patient.
- Currently enrolled in a study or intervention domain that does not permit co-enrollment.
- Prior enrollment in the specific platform trial intervention domain.
- Patient or legally authorized representative did not provide informed consent (declined participation).
- Eligible patient or legally authorized representative was not approached within the screening window (missed participant).
- Other reasons to exclude the patient, as approved by the data coordinating center.
- Associated lower extremity injury that prevents post-operative weight-bearing.
- Retained hardware around the hip that precludes either study treatment.
- Infection around the hip (soft tissue or bone).
- Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation.
- Injury did not occur within 21 days of screening.
- Patient is too ill, in the judgment of the attending surgeon, for internal fixation.
- Patient is too ill, in the judgment of the attending surgeon, for arthroplasty.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Artroplastia da anca
|
Participants will undergo surgical treatment using standard hip arthroplasty techniques for femoral minimally displaced femoral neck fracture. A modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. The type of hip prosthesis (hemiarthroplasty or total hip arthroplasty), bearing (single or dual mobility), or the method of arthroplasty fixation (cemented or uncemented) will be at the discretion of the treating surgeon. |
|
Comparador Ativo: Fixação interna
|
Participants will undergo surgical treatment using standard fixation techniques for minimally displaced femoral neck fractures. The treating surgeon may perform fracture reduction maneuvers if desired. Fixed-angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. Internal fixation constructs combining cancellous screws and fixed-angle devices will be permitted. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Composite outcome of death, ambulation status, and days alive and out of hospital.
Prazo: 120 days after randomization
|
Death consists of time to all-cause mortality. Ambulation will be evaluated using an ordinal ranking of independence. Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
120 days after randomization
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Composite outcome of death, ambulation status, and days alive and out of hospital.
Prazo: 365 days after randomization
|
Death consists of time to all-cause mortality. Ambulation will be evaluated using an ordinal ranking of independence. Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
365 days after randomization
|
|
Death
Prazo: 120 days post-randomization
|
Death consists of time to all-cause mortality. |
120 days post-randomization
|
|
Death
Prazo: 12 months post-randomization
|
Death consists of time to all-cause mortality. |
12 months post-randomization
|
|
Ambulation status
Prazo: 120 days post-randomization
|
Ambulation will be evaluated using an ordinal ranking of independence |
120 days post-randomization
|
|
Ambulation status
Prazo: 12 months post-randomization
|
Ambulation will be evaluated using an ordinal ranking of independence |
12 months post-randomization
|
|
Days alive and out of hospital
Prazo: 120 days post-randomization
|
Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
120 days post-randomization
|
|
Days alive and out of hospital
Prazo: 12 months post-randomization
|
Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
12 months post-randomization
|
|
Health-related quality of life
Prazo: 120 days days post-randomization
|
EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health |
120 days days post-randomization
|
|
Health-related quality of life
Prazo: 12 months post-randomization
|
EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health |
12 months post-randomization
|
|
Numeric Pain Rating Scale
Prazo: During hospitalization in the first seven postoperative days
|
The highest level of pain recorded daily in the participant's medical record - Range: 0-10, higher score indicates higher level of pain |
During hospitalization in the first seven postoperative days
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Joseph T Patterson, MD, University of Southern California
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Ferimentos e Lesões
- Lesões nas pernas
- Fraturas, Osso
- Lesões do quadril
- Fraturas Femorais
- Fraturas de quadril
- Fraturas do colo do fêmur
- Terapêutica
- Procedimentos cirúrgicos, operatórios
- Artroplastia, substituição
- Artroplastia
- Procedimentos ortopédicos
- Procedimentos de cirurgia plástica
- Implante de prótese
- Fixação de fraturas
- Artroplastia, substituição, quadril
- Fixação de fraturas, interna
Outros números de identificação do estudo
- BPS-2024C1-37436
- BPS-2024C1-37436 (Número de outro subsídio/financiamento: Patient-Centered Outcomes Research Institute)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .